French international pioneer in respiratory health.

Based in Nice, this excellence center aims to develop innovative approaches for diagnosing, treating and preventing respiratory diseases.

Our Upcoming Events

Congrès international à Nice pour explorer l'impact de l’IA en pathologie thoracique et ses applications cliniques en santé respiratoire.
Events
AI in the Next World of Thoracic Pathology
10/06/2026
- 10/07/2026
In Nice, an international congress will explore the role of artificial intelligence in making thoracic pathology diagnosis faster, more precise and more personalized.

Our News

The RespirERA Institute acquires the NovaSeq X to accelerate genomic and multi-omics research on respiratory diseases.
Featured
The RespirERA Institute strengthens its research capabilities with the acquisition of the NovaSeq X
With the acquisition of the NovaSeq X, the RespirERA Institute strengthens its genomics platform to accelerate the analysis of respiratory diseases and support the development of more personalised medicine.
The RespirERA Institute is participating in the SOPHiA GENETICS Innovation Summit 2026, dedicated to innovations in precision medicine, biomarkers, and artificial intelligence.
News
Liquid biopsy and precision medicine: the challenges of large-scale deployment
Professor Paul Hofman, Director of the RespirERA Institute, took part in the SOPHiA GENETICS Innovation Summit 2026, an international event dedicated to innovations in precision medicine. This event...
A review published in Lung Cancer highlights the role of biomarkers in guiding the use of new targeted treatments for lung cancer.
Publication
Lung cancer: better identifying patients who may benefit from new targeted treatments
RespirERA Institute experts review biomarkers guiding new targeted treatments in lung cancer.

Our Strategic Priorities

IHU RespirERA structures its actions around four complementary strategic priorities. Together, they aim to improve the understanding and prevention of respiratory diseases, enhance their diagnosis, personalize patient care, and widely disseminate research-driven innovations for the benefit of patients and society.

Our Missions

IHU RespirERA is committed to five key missions to explore the impact of aging and the environment on respiratory health, placing the patient at the heart of its projects.
Understand

the mechanisms of respiratory diseases to better address them.

Prevent

by identifying environmental risk factors and developing effective prevention strategies.

Treat

by creating personalized treatments tailored to each patient’s specific needs.

Innovate

by integrating new technologies, including artificial intelligence and robotics, to enhance diagnosis and care.

Educate & Train

healthcare professionals and the general public on emerging technologies and best practices.

Our Strategy

IHU RespirERA is built on a synergy between researchers, clinicians, patient associations, and industry partners, fostering effective collaboration to understand and treat respiratory diseases. This holistic approach considers all aspects of these pathologies, from biological factors to environmental impacts, to develop comprehensive and innovative solutions. The Provence-Alpes-Côte d’Azur region, significantly affected by pollution and an aging population, serves as our "living laboratory", enabling us to develop real-world solutions tailored to environmental and health challenges.

Our Projects

Discover our flagship projects that need your support!

Liquid biopsy: a blood test to diagnose lung cancer
Toward more precise and less invasive diagnosis of lung cancer for better targeted treatments
Innovative biomarkers: tissue, liquid and AI
Towards earlier diagnosis and targeted treatments thanks to innovative biomarkers, liquid biopsy and AI.
Dépistage du cancer du poumon
IHU RespirERA is a leading actor in the deployment of lung cancer screening in France.

Support Us

to give new life to research!

By supporting IHU RespirERA, you are directly contributing to the funding of our innovative projects across all areas of respiratory health.

Every donation is a breath of fresh air for research.

Our Founding Members

Our Institutional Support

Supported by the ANR through France 2030: ANR-23-IAHU-0007